Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HT074 is a proprietary botanical extract complex developed by the South Korean biotechnology company **Neumed**. It is primarily composed of a standardized extract of Peony (*Paeonia lactiflora*) and other synergistic herbal components. HT074 has been recognized by the South Korean Ministry of Food and Drug Safety (MFDS) as a functional ingredient for maintaining and improving gastric health. The extract is designed to provide cytoprotective effects on the gastric mucosa, helping to protect the stomach lining from irritation and reducing symptoms of functional dyspepsia or general stomach discomfort. It is typically utilized as an active ingredient in health functional foods (nutraceuticals) rather than as a prescription pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HT074.